Literature DB >> 1470696

The management of carcinoma of the anal canal by external beam radiotherapy, experience in Vancouver 1971-1988.

G Newman1, D C Calverley, B D Acker, M Manji, J Hay, A D Flores.   

Abstract

From 1971 to 1988 72 cases of carcinoma of the anal canal were treated by external beam radiotherapy, most commonly by 5000 cGy in 20 fractions given over 4 weeks. The actuarial survival at 5 years was 66% and the disease specific survival 78%. Nine patients had inguinal node metastases at diagnosis; their 5-year disease specific survival was 75%. 63 patients were inguinal node negative at presentation; their 5-year disease specific survival was 78%, by UICC 1987 staging: T1 71%, T2 88%, T3 41%, T4 42%. 17 patients developed local recurrence; 10 were suitable for abdominoperineal (AP) resection which was successful in 7. The probability of local control was related to T stage. 13 patients were left with a colostomy because of recurrence, 2 had a colostomy for radiation damage and 4 had their local recurrence managed palliatively, without a colostomy. As a result, 53 of the 72 patients (74%) were left with a functional anus. Severe late complications occurred in 6 (8%).

Entities:  

Mesh:

Year:  1992        PMID: 1470696     DOI: 10.1016/0167-8140(92)90268-y

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

Review 1.  Radiotherapy alone versus chemoradiotherapy for stage I anal squamous cell carcinoma: a systematic review and meta-analysis.

Authors:  Gaurav Talwar; Ryan Daniel; Tyler McKechnie; Oren Levine; Cagla Eskicioglu
Journal:  Int J Colorectal Dis       Date:  2021-01-24       Impact factor: 2.571

2.  ACR Appropriateness Criteria®-Anal Cancer.

Authors:  Theodore S Hong; Jennifer L Pretz; Joseph M Herman; May Abdel-Wahab; Nilofer Azad; A William Blackstock; Prajnan Das; Karyn A Goodman; Salma K Jabbour; William E Jones; Andre A Konski; Albert C Koong; Miguel Rodriguez-Bigas; William Small; Charles R Thomas; Jennifer Zook; W Warren Suh
Journal:  Gastrointest Cancer Res       Date:  2014-01

3.  SEOM clinical guidelines for the treatment of anal cancer.

Authors:  Joan Maurel; Carlos Fernández-Martos; Jaime Feliu; Dolores Isla
Journal:  Clin Transl Oncol       Date:  2011-08       Impact factor: 3.405

4.  Premalignant lesions of the anal canal and squamous cell carcinoma of the anal canal.

Authors:  Juan Lucas Poggio
Journal:  Clin Colon Rectal Surg       Date:  2011-09

Review 5.  De-Escalation of Therapy for Patients with Early-Stage Squamous Cell Carcinoma of the Anus.

Authors:  Eric Miller; Jose Bazan
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

6.  Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC).

Authors:  R Fish; C Sanders; N Ryan; S Van der Veer; A G Renehan; P R Williamson
Journal:  Colorectal Dis       Date:  2018-04-17       Impact factor: 3.788

7.  Racial disparities in receipt of standard chemoradiation in anal squamous cell carcinoma, an analysis of the National Cancer Database.

Authors:  Shelly X Bian; Dennis H Chen; Eugene Lin
Journal:  Cancer Med       Date:  2020-12-11       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.